Augmentin ES (Amoxicillin) powder for oral suspension 600mg/42.9mg /5 ml bottle with measuring spoon — Made in Poland — Free Delivery

Brand: GlaxoSmithKline
Product Code: Augmentin ES (Amoxicillin) 600mg/42.9mg
Availability: 2 - 3 Days

$29.69

Description

Product description

Powder for oral suspension "Augmentin ™ ES" is used for infections in children aged 3 months and older, whose body weight does not exceed 40 kg, caused or presumably caused by penicillin-resistant strains of Streptococcus pneumoniae:

acute otitis media;
community-acquired pneumonia.

Composition

1 bottle contains powder for preparation of 100 ml of a suspension of the following composition: 5 ml of suspension contain (active ingredients) amoxicillin (in the form of amoxicillin trihydrate) 600 mg of clavulanic acid (in the form of potassium clavulanate) 42.9 mg.

Excipients: colloidal anhydrous silicon dioxide, sodium carboxymethyl cellulose 12, aspartame (E 951), xanthan gum, silicon dioxide, artificial strawberry flavor.

Contraindications

hypersensitivity to the components of the preparation, to any antibacterial agents of the penicillin group;
a history of severe hypersensitivity reactions (including anaphylaxis) associated with the use of other beta-lactam agents (including cephalosporins, carbapenems, or monobactams);
a history of jaundice or liver dysfunction associated with the use of amoxicillin / clavulanic acid.

Mode of application

The dosage is expressed in terms of the content of amoxicillin / clavulanic acid, unless the dosage is expressed in terms of the individual component.

When choosing the dosage of the preparation for the treatment of an individual infection, one should consider:

probable causative agents of the disease and their possible sensitivity to antibacterial preparations;
the severity and localization of the infection;
the age, body weight, and renal function of the patient, as indicated below.
The course of treatment should not exceed 14 days without viewing it.

Adults and children weighing ≥ 40 kg

There is no experience of using "Augmentin ™", suspension, for adults and children weighing ≥ 40 kg, therefore there are no recommendations regarding dosage for these groups of patients.

Children aged from 3 months with a body weight of <40 kg

The recommended dose of the preparation "Augmentin ™" is 90 / 6.4 mg / kg / day, in 2 divided doses.

Augmentin ™ ES contains a different amount of clavulanic acid (in the form of potassium salt) than any other form of Augmentin ™ suspension. "Augmentin ™ ES" contains 42.9 mg of clavulanic acid per 5 ml of suspension, while the suspension of "Augmentin ™" 200 mg / 5 ml contains 28.5 mg of clavulanic acid per 5 ml, and the suspension of 400 mg / 5 ml contains 57 mg clavulanic acid per 5 ml. Therefore, Augmentin ™ ES cannot be replaced by any other form of Augmentin ™ suspension.

Method of use

Augmentin ™ ES is intended for oral administration.

The preparation should be taken with meals to minimize potential gastrointestinal intolerance.

Instructions for preparing a suspension. Before use, check the integrity of the seal on the lid. Shake the bottle to loosen the powder. Add the required amount of water (as indicated below), invert and shake well. Alternatively, fill the bottle with water just below the mark on the label, turn over and shake thoroughly, then fill the bottle with water up to the mark, turn over and shake well again.

Dosage 600 mg / 42.9 mg / 5 ml:

the volume of water that must be added for dissolution - 90 ml;

the final volume of the dissolved oral suspension is 100 ml.

Shake the bottle thoroughly before each use.

Application features

Pregnant

The use of the preparation during pregnancy should be avoided, unless the doctor considers it necessary.

Both active components of the preparation are excreted in breast milk (there is no information on the effect of clavulanic acid on a breastfed infant). Accordingly, a baby who is breastfed may develop diarrhea and a fungal infection of the mucous membranes, so breastfeeding should be discontinued. The possibility of allergic reactions should be taken into account. Amoxicillin / clavulanic acid should be used during breastfeeding only when, in the opinion of the doctor, the benefits of use outweigh the risks.

Drivers

Studies on the ability of the preparation to influence the reaction rate when driving vehicles and working with mechanisms have not been carried out. However, undesirable effects (such as allergic reactions, dizziness, convulsions) may occur, which may affect the ability to drive and operate machinery.

Overdose

Symptoms

Symptoms of gastrointestinal upset and fluid and electrolyte imbalance may occur. Crystalluria was observed associated with the intake of amoxicillin, which in some cases led to the development of renal failure.

In patients with impaired renal function and in patients taking high doses of the preparation, seizures may occur.

Amoxicillin sediments have been reported in bladder catheters, predominantly after high-dose administration.

The patency of the catheters should be checked regularly.

Treatment

Gastrointestinal disorders can be treated symptomatically by paying attention to fluid / electrolyte balance. Amoxicillin / clavulanic acid can be removed from the bloodstream by hemodialysis.

Side effects

The most commonly reported adverse reactions to the preparationwere diarrhea, nausea and vomiting.

Storage conditions

Store at a temperature not exceeding 25 ° C, out of the reach of children.

Store the prepared suspension in a refrigerator at a temperature of 2 ° C to 8 ° C and use it within 10 days. Do not freeze.

Shelf life - 2 years (prepared suspension - 10 days).

0 reviews

There are no reviews for this product.